Search

Your search keyword '"Kroll, S."' showing total 6 results
Start Over Author "Kroll, S." Journal annals of oncology
6 results on '"Kroll, S."'

1. CONTESSA TRIO: A multinational, multicenter, phase II study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with her2- metastatic breast cancer (MBC)

Author

Tolaney, S.M., primary, Blum, J.L., additional, Bondarenko, I., additional, Chan, A., additional, DaCosta, N., additional, Feng, Y.-H., additional, Izarzugaza, Y., additional, Kim, S.-B., additional, Liu, M.-C., additional, Oliveira, M., additional, Ow, S.G.W., additional, Pavic, M., additional, Peréz Lopéz, M.E., additional, Rugo, H.S., additional, Schwartzberg, L., additional, Stradella, A., additional, Kroll, S., additional, O’Connell, J., additional, Wei, T., additional, and Mittendorf, E.A., additional

Published
2019
Full Text
View/download PDF

2. 382TiP - CONTESSA TRIO: A multinational, multicenter, phase II study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with her2- metastatic breast cancer (MBC)

Author

Tolaney, S.M., Blum, J.L., Bondarenko, I., Chan, A., DaCosta, N., Feng, Y.-H., Izarzugaza, Y., Kim, S.-B., Liu, M.-C., Oliveira, M., Ow, S.G.W., Pavic, M., Peréz Lopéz, M.E., Rugo, H.S., Schwartzberg, L., Stradella, A., Kroll, S., O’Connell, J., Wei, T., and Mittendorf, E.A.

Published
2019
Full Text
View/download PDF

3. Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021

Author

Tap, W., primary, Papai, Z., additional, van Tine, B., additional, Attia, S., additional, Ganjoo, K., additional, Jones, R.L., additional, Schuetze, S., additional, Reed, D., additional, Chawla, S.P., additional, Riedel, R., additional, Krarup-Hansen, A., additional, Italiano, A., additional, Hohenberger, P., additional, Grignani, G., additional, Cranmer, L., additional, Alcindor, T., additional, Lopez-Pousa, A., additional, Pearce, T., additional, Kroll, S., additional, and Schoffski, P., additional

Published
2016
Full Text
View/download PDF

5. 1395O - Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021

Author

Tap, W., Papai, Z., van Tine, B., Attia, S., Ganjoo, K., Jones, R.L., Schuetze, S., Reed, D., Chawla, S.P., Riedel, R., Krarup-Hansen, A., Italiano, A., Hohenberger, P., Grignani, G., Cranmer, L., Alcindor, T., Lopez-Pousa, A., Pearce, T., Kroll, S., and Schoffski, P.

Published
2016
Full Text
View/download PDF

6. O-0008 Phase II Study of Gemcitabine + TH-302 vs Gemcitabine Alone in Patients with Locally Advanced and Metastatic Pancreatic Cancer

Author

Ryan, D., primary, Reddy, S., additional, Bahary, N., additional, Uronis, H., additional, Sigal, D.S., additional, Cohn, Allen, additional, Schelman, W.R., additional, Chiorean, E.G., additional, Rosen, P.J., additional, Ulrich, B., additional, Dragovich, T., additional, Del Prete, S., additional, Rarick, M., additional, Eng, C., additional, and Kroll, S., additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results